Leon A. Boston

Leon-Ariel Boston is a seasoned executive with extensive experience in the healthcare and pharmaceutical sectors. Currently serving as the Co-Founder of Imyun Pharmaceuticals since January 2024, Leon-Ariel is instrumental in advancing a novel technology aimed at eradicating hard-to-treat tumors. Previously, as Chief Executive Officer at MobileODT from 2020 to June 2024, Leon-Ariel led the company in innovative solutions, and prior to that, held the position of CEO at NeuroIndex Ltd. from April 2017 to January 2020, where Leon-Ariel oversaw the development of an intra-operative brain monitoring device. Leon-Ariel’s career also includes roles as COO at MPS Medical, Inc. and CEO & Founder at Boston Medical Technologies, Inc., specializing in telemedicine for cardiovascular health. Earlier experience includes directing sales and business development at Itamar Medical, where Leon-Ariel contributed to the advancement of diagnostic devices for cardiovascular and sleep health. Leon-Ariel holds a Bachelor of Commerce degree in Economics, Business Administration, and Political Science from the University of South Africa/Universiteit van Suid-Afrika.